1. ASCO 2023 news drops ahead of June meeting: Merck, BMS, Regeneron, and more — Noom to offer prescriptions for weight-loss drugs --ASCO puts spotlight on advancing antibody-drug conjugate pipeline -- See more on our front page news http://bit.ly/w28kSd See more on our front page news
    Dismiss Notice

PTC Therapeutics

Discussion in 'Ask a Whistleblower Attorney' started by anonymous, Mar 29, 2022 at 7:24 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Two of the pipeline programs, including PTC518 for Huntington, are on clinical hold and the company did not mention publicly. I tried complaining internally, but they don't care.

    What should I do?

  2. anonymous

    anonymous Guest

    PTC Provides Update on Ongoing Global PIVOT-HD Trial For PTC518

    the fraud continues. The company continues to mislead everyone.
  3. First call a lawyer. They would be able to help you to talk to the SEC.
  4. anonymous

    anonymous Guest

    What are the lies? Their press releases are so vague
  5. anonymous

    anonymous Guest

    many areas - clinical hold in the USA to a maximum dose of 5mg for PTC518 due to severe toxicity in animals, e.g. irreversible nerve damage in monkeys, and genotoxicity. Trial is stopped in the US without any plans or potential to start again
    - undisclosed clinical hold with aadc in the US earlier this year
    - clear issues with the ataluren FDA discussions, not what we said in the press release, much more clear
    basically many programs without a future in the US.